Insulin Icodec Weekly: A Basal Insulin Analogue for Type 2 Diabetes

Insulin icodec is a once-weekly basal insulin analogue in late-phase clinical development. Similar efficacy and safety of icodec to once-daily basal insulin analogues have been reported in over 4,200 participants with type 2 diabetes from three phase II and five phase III trials. Indeed, glycated ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Bajaj, Harpreet S, Goldenberg, Ronald M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Touch Medical Media 2023
Materias:
Diabetes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258611/
https://www.ncbi.nlm.nih.gov/pubmed/37313230
http://dx.doi.org/10.17925/EE.2023.19.1.4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258611/
https://www.ncbi.nlm.nih.gov/pubmed/37313230
http://dx.doi.org/10.17925/EE.2023.19.1.4

Ejemplares similares